Scientific guidance from internationally recognised leaders

MiND’s Scientific Advisory Board brings together respected researchers and clinicians across molecular biology, epigenetics, neurology, neuroscience, virology and immunology. Their guidance supports our scientific strategy as we advance biomarker discovery and validation.

Sir Gregory Winter
Nobel Laureate and pioneering molecular biologist whose work helped transform therapeutic antibody development. Awarded the Nobel Prize in Chemistry in 2018, Sir Gregory brings a perspective shaped by fundamental scientific discovery and its translation into medicines.

Professor Dominic Rowe
Clinical neurologist and researcher with extensive experience in motor neurone disease and Parkinson’s disease. His work spans patient care and research into the clinical, genetic and biological aspects of neurodegeneration, bringing an important clinical perspective to biomarker development.

Professor Susan Clark
An internationally recognised epigenetics researcher whose work has advanced understanding of gene regulation and disease. Her experience includes methylation-based cancer diagnostics, bringing insight into the connection between epigenetic discovery and practical molecular testing.

Professor Lezanne Ooi
Neuroscientist whose research spans neurodevelopment and neurodegeneration. Her work investigates neuronal function, neuroinflammation and potential therapeutic approaches using cellular and molecular models, contributing expertise in disease biology and experimental research.

Professor Bill Rawlinson
Medical virologist with extensive experience in clinical diagnostics, reference laboratories and public health. His work combines laboratory medicine and research, contributing a perspective on diagnostic development and its application in healthcare.

Professor Marc Pellegrini
Immunologist and medical research leader with expertise in chronic disease and translational research. His work has contributed to clinical studies and therapeutic development, bringing experience in progressing biological insights towards potential applications.
Partner with us
MiND Biosciences is committed to advancing biomarker discovery through collaboration. We welcome opportunities to work with researchers, clinicians, industry partners and investors who share our vision for earlier, more precise diagnosis.